Reduces drug effectiveness
Avoid high-dose folic acid during malaria treatment.
Reduces drug levels
Monitor phenytoin levels when adding folic acid.
Reduces drug effectiveness
Avoid with cancer-dose methotrexate. USE with low-dose methotrexate.
Enhances drug toxicity
Do not supplement during fluorouracil-based chemotherapy.
L-methylfolate supplements show wild variation: 0-280% of labeled amount in one study. Folic acid is more stable and reliable.
Not Prohibited.
L-methylfolate supplements show wild variation: 0-280% of labeled amount in one study. Folic acid is more stable and reliable.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated: April 5, 2026
Not medical advice. Based on published clinical research and systematic reviews.
Folic Acid · interaction landscape
3 flagged
0
Dangerous
3
Moderate
0
Timing
0
Pre-op
Safety
Moderate interactions. Monitoring, timing separation, or dose adjustment may be required.
Methotrexate
SourceFDA label
Phenytoin (Dilantin)
SourceClinical pharmacology
5-Fluorouracil (5-FU)
SourceOncology standard
Educational information only. This is not medical advice. These statements have not been evaluated by the FDA. Talk to your prescriber before starting, stopping, or combining any supplement with prescription medication.